Table of Content

1 Study Coverage
1.1 Glucosylceramidase Product Introduction
1.2 Global Glucosylceramidase Outlook 2018 VS 2023 VS 2029
1.3 United States Glucosylceramidase Outlook 2018 VS 2023 VS 2029
1.4 Glucosylceramidase Market Size, United States VS Global, 2018-2029
1.4.1 The Market Share of United States Glucosylceramidase in Global, 2018-2029
1.4.2 The Growth Rate of Glucosylceramidase Market Size, United States VS Global, 2018 VS 2023 VS 2029
1.5 Glucosylceramidase Market Dynamics
1.5.1 Glucosylceramidase Market Trends
1.5.2 Glucosylceramidase Market Drivers
1.5.3 Glucosylceramidase Market Challenges
1.5.4 Glucosylceramidase Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Coronavirus Disease (COVID-19) Impact on Global
2 Global Glucosylceramidase Competitor Landscape by Company
2.1 Global Glucosylceramidase Market Size by Company
2.1.1 Top Global Glucosylceramidase Player Ranked by Revenue (2023)
2.1.2 Global Glucosylceramidase Revenue by Player (2018-2023)
2.2 Global Glucosylceramidase Concentration Ratio (CR)
2.2.1 Glucosylceramidase Market Concentration Ratio (CR) (2018-2023)
2.2.2 Global Top 3 and Top 6 Largest Players of Glucosylceramidase in 2023
2.3 Global Glucosylceramidase Business Distribution, Business Type
2.3.1 Global Glucosylceramidase Players, Headquarters and Distribution
2.3.2 Players Glucosylceramidase Business Type
2.3.3 Date of International Players Enter into Glucosylceramidase Market
2.4 Players Mergers & Acquisitions, Expansion Plans
2.5 United States Glucosylceramidase Market Size by Company
2.5.1 Top United States Glucosylceramidase Player s Ranked by Revenue (2023)
2.5.2 United States Glucosylceramidase Revenue by Player (2018-2023)
3 Glucosylceramidase Market Segment by Type
3.1 Glucosylceramidase Market Segment by Type
3.2 Global Glucosylceramidase Market Size by Type
3.3 United States Glucosylceramidase Market Size by Type
4 Glucosylceramidase Market Segment by Application
4.1 Glucosylceramidase Market Segment by Application
4.2 Global Glucosylceramidase Market Size by Application
4.3 United States Glucosylceramidase Market Size by Application
5 Global Glucosylceramidase Market Size by Region
5.1 Global Glucosylceramidase Market Size by Region: 2018 VS 2023 VS 2029
5.2 Global Glucosylceramidase Market Size in Value by Region (2018-2029)
5.2.1 Global Glucosylceramidase Revenue by Region: 2018-2023
5.2.2 Global Glucosylceramidase Revenue by Region: 2023-2029
5.3 Global Glucosylceramidase Market Size in Volume by Region (2018-2029)
5.3.1 Global Glucosylceramidase Volume by Region: 2018-2023
5.3.2 Global Glucosylceramidase Volume by Region: 2023-2029
6 Segment in Regional Level & Country Level
6.1 North America
6.1.1 North America Glucosylceramidase Market Size YoY Growth 2018-2029
6.1.2 North America Glucosylceramidase Market Facts & Figures by Country (2018-2029)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia Pacific
6.2.1 Asia Pacific Glucosylceramidase Market Size YoY Growth 2018-2029
6.2.2 Asia Pacific Glucosylceramidase Market Facts & Figures by Country (2018-2029)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Southeast Asia
6.3 Europe
6.3.1 Europe Glucosylceramidase Market Size YoY Growth 2018-2029
6.3.2 Europe Glucosylceramidase Market Facts & Figures by Country (2018-2029)
6.3.3 Germany
6.3.4 France
6.3.5 UK
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Glucosylceramidase Market Size YoY Growth 2018-2029
6.4.2 Latin America Glucosylceramidase Market Facts & Figures by Country (2018-2029)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Glucosylceramidase Market Size YoY Growth 2018-2029
6.5.2 Middle East and Africa Glucosylceramidase Market Facts & Figures by Country (2018-2029)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Amicus Therapeutics, Inc.
7.1.1 Amicus Therapeutics, Inc. Company Details
7.1.2 Description and Business Overview
7.1.3 Glucosylceramidase Introduction
7.1.4 Amicus Therapeutics, Inc. Glucosylceramidase Revenue, Sales, and Gross Margin (2018-2023)
7.1.5 Amicus Therapeutics, Inc. Recent Development
7.2 Bioorganic Research and Services S.A.
7.2.1 Bioorganic Research and Services S.A. Company Details
7.2.2 Description and Business Overview
7.2.3 Glucosylceramidase Introduction
7.2.4 Bioorganic Research and Services S.A. Glucosylceramidase Revenue, Sales, and Gross Margin (2018-2023)
7.2.5 Bioorganic Research and Services S.A. Recent Development
7.3 greenovation Biotech GmbH
7.3.1 greenovation Biotech GmbH Company Details
7.3.2 Description and Business Overview
7.3.3 Glucosylceramidase Introduction
7.3.4 greenovation Biotech GmbH Glucosylceramidase Revenue, Sales, and Gross Margin (2018-2023)
7.3.5 greenovation Biotech GmbH Recent Development
7.4 JCR Pharmaceuticals Co., Ltd.
7.4.1 JCR Pharmaceuticals Co., Ltd. Company Details
7.4.2 Description and Business Overview
7.4.3 Glucosylceramidase Introduction
7.4.4 JCR Pharmaceuticals Co., Ltd. Glucosylceramidase Revenue, Sales, and Gross Margin (2018-2023)
7.4.5 JCR Pharmaceuticals Co., Ltd. Recent Development
7.5 Pharming Group N.V.
7.5.1 Pharming Group N.V. Company Details
7.5.2 Description and Business Overview
7.5.3 Glucosylceramidase Introduction
7.5.4 Pharming Group N.V. Glucosylceramidase Revenue, Sales, and Gross Margin (2018-2023)
7.5.5 Pharming Group N.V. Recent Development
7.6 Protalix BioTherapeutics, Inc.
7.6.1 Protalix BioTherapeutics, Inc. Company Details
7.6.2 Description and Business Overview
7.6.3 Glucosylceramidase Introduction
7.6.4 Protalix BioTherapeutics, Inc. Glucosylceramidase Revenue, Sales, and Gross Margin (2018-2023)
7.6.5 Protalix BioTherapeutics, Inc. Recent Development
7.7 Takeda
7.7.1 Takeda Company Details
7.7.2 Description and Business Overview
7.7.3 Glucosylceramidase Introduction
7.7.4 Takeda Glucosylceramidase Revenue, Sales, and Gross Margin (2018-2023)
7.7.5 Takeda Recent Development
7.8 The International Biotechnology Center (IBC) Generium
7.8.1 The International Biotechnology Center (IBC) Generium Company Details
7.8.2 Description and Business Overview
7.8.3 Glucosylceramidase Introduction
7.8.4 The International Biotechnology Center (IBC) Generium Glucosylceramidase Revenue, Sales, and Gross Margin (2018-2023)
7.8.5 The International Biotechnology Center (IBC) Generium Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Glucosylceramidase Value Chain Analysis
8.2 Glucosylceramidase Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Distributors List
8.3 Glucosylceramidase Production Mode & Process
8.4 Glucosylceramidase Sales and Marketing
8.4.1 Magnetic Coupled Mixers Sales Channels
8.4.2 Magnetic Coupled Mixers Distributors
8.5 Magnetic Coupled Mixers Customers
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 A Methodology
10.1.1 Research Process
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 B Data Source
10.2.1 Legal Disclaimer